Federal data show a fast rise in “superbug” Shigella, with extensively drug-resistant strains reaching 8.5% of tested samples in 2023, shrinking treatment options and raising public-health risks.
Story Highlights
- Centers for Disease Control and Prevention (CDC) reports a jump in extensively drug-resistant Shigella to 8.5% of isolates in 2023.
- CDC estimates hundreds of thousands of drug-resistant Shigella infections occur in the United States each year.
- Officials warn some strains resist all commonly recommended antibiotics, complicating care.
- Rising resistance mirrors broader gaps in surveillance, treatment access, and basic sanitation.
CDC Trend: Drug Resistance Is Climbing
CDC scientists analyzed national laboratory data from 2011 through 2023 and found a clear trend. The share of Shigella samples that were extensively drug-resistant rose from 0% in 2011–2015 to 8.5% in 2023, among nearly 17,000 isolates with resistance results. This pattern follows earlier CDC alerts about growing resistance to key drugs like ciprofloxacin and azithromycin. Health officials now track resistant Shigella as a priority threat that can spread easily in close-contact settings.
CDC defines extensively drug-resistant Shigella as strains that resist all commonly recommended empiric and alternative antibiotics. That includes azithromycin, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and ampicillin. When these drugs fail, doctors have fewer choices, and some options may require hospital care. CDC has noted that certain alternative agents might still work in select cases, but those are not standard first-line drugs and can be harder to use.
Why This Matters for Families and Communities
Shigella spreads through the fecal-oral route. People can get sick from tiny amounts of contaminated stool on hands, surfaces, food, or water. Close personal contact, including some forms of sexual contact, can also spread it. Because the infectious dose is low, outbreaks can hit fast in child care, shelters, jails, and tight social networks. CDC estimates that antimicrobial-resistant Shigella infections number in the hundreds of thousands each year in the United States.
Rising resistance raises the odds that common antibiotics will not work. That can lead to longer illness, more dehydration, and more emergency visits. It also pressures hospitals and local health departments already stretched by other outbreaks. While most people recover, those with weak immune systems, young children, and older adults face higher risk of severe disease. Early testing and careful hygiene can slow spread and guide the right treatment.
Health System Gaps and What Government Can Do
CDC surveillance relies on reported infections and lab-tested samples. That shows strong trends but may miss untested cases. Officials have warned since at least 2016 about rising resistance to key drugs, and they updated alerts as resistance patterns grew. This slow, steady climb reveals a familiar problem. Public systems react after resistance spreads, not before. That delay leaves families, workers, and small clinics holding the risk while costs climb.
Condoms cannot fully stop it.
For some extremely drug resistant strains (XDR) of the bug, no approved oral antibiotic is left for treatment.
Nearly half also had HIV.
Sexually transmitted diarrhea is rising in the US. CDC data show the resistant strains are mostly in adult… pic.twitter.com/C2W8bqB8Wv
— Dr. AK 🇮🇳 (@docakx) October 9, 2026
Basic steps still work. Handwashing with soap, staying home when sick, and cleaning shared spaces reduce spread. Clinicians should order stool cultures and susceptibility tests for severe or high-risk cases. They should avoid antibiotics unless needed, to protect remaining drug options. Federal and state leaders can expand lab capacity, share data faster, and fund sanitation in schools, shelters, and detention facilities. These concrete actions protect everyone, regardless of politics or zip code.
Who Is Most Affected Right Now
Earlier CDC analyses found higher risk in certain groups, including men who have sex with men, people experiencing homelessness, international travelers, and those with weak immune systems. These settings often involve close contact, shared facilities, or limited access to care. That makes prevention harder and delays testing and treatment. Targeted outreach, rapid testing access, and practical support for isolation when ill can cut spread without blaming people who are already vulnerable.
Bottom Line for Households
Families should watch for fever, stomach cramps, and diarrhea that may be bloody. People with severe symptoms or dehydration should seek care and ask about testing. If a doctor prescribes treatment, take it exactly as directed. Avoid preparing food for others while sick, and disinfect high-touch surfaces. These steps are simple, but they work. They buy time while health agencies and hospitals race to keep effective medicines on the shelf.
Sources:
insiderpaper.com, cdc.gov, wwwnc.cdc.gov, archive.cdc.gov, cidrap.umn.edu
